Varian Medical Systems, Inc.  

(Public, NYSE:VAR)   Watch this stock  
Find more results for VAR
+2.05 (2.57%)
Aug 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 79.56 - 81.92
52 week 76.73 - 96.67
Open 80.90
Vol / Avg. 994,384.00/807,286.00
Mkt cap 7.87B
P/E 19.85
Div/yield     -
EPS 4.12
Shares 98.72M
Beta 0.85
Inst. own 98%
Oct 28, 2015
Q4 2015 Varian Medical Systems Inc Earnings Release - 4:00PM EDT - Add to calendar
Sep 17, 2015
Varian Medical Systems Inc at Morgan Stanley Healthcare Conference Add to calendar
Sep 9, 2015
Varian Medical Systems Inc at Robert W Baird and Co Health Care Conference Add to calendar
Aug 28, 2015
Varian Medical Systems Inc at Pareto Securities Healthcare Conference Add to calendar
Jul 29, 2015
Q3 2015 Varian Medical Systems Inc Earnings Call
Jul 29, 2015
Q3 2015 Varian Medical Systems Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '15) 2014
Net profit margin 14.49% 13.24%
Operating margin 18.40% 18.73%
EBITD margin - 21.15%
Return on average assets 13.04% 11.83%
Return on average equity 26.76% 24.24%
Employees 6,800 -
CDP Score - 89 C


3100 Hansen Way
PALO ALTO, CA 94304-1030
United States - Map
+1-650-4245834 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Company’s products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Company’s customers include university research and community hospitals, private and governmental institutions, healthcare agencies, doctors’ offices and cancer care clinics.

Officers and directors

R. Andrew Eckert Independent Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Dow R. Wilson President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kolleen T. Kennedy President - Oncology Systems, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Timothy E. Guertin Vice Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Elisha W. Finney Chief Financial Officer, Executive Vice President - Finance
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Clarence R. Verhoef Senior Vice President - Finance, Corporate Controller
Age: 59
Bio & Compensation  - Reuters
John W. Kuo Senior Vice President, General Counsel, Corporate Secretary
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Sunny Sanyal Senior Vice President; President, Imaging Components Businesses
Age: 50
Bio & Compensation  - Reuters
Susan L. Bostrom Independent Director
Age: 54
Bio & Compensation  - Reuters
Regina E. Dugan Ph.D. Independent Director
Age: 52
Bio & Compensation  - Reuters